Company Corbus Pharmaceuticals Holdings, Inc.
Equities
CRBP
US21833P3010
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.99 USD | -1.71% | +10.88% | +611.75% |
Business Summary
Number of employees: 19
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 30/06/13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 10/04/14 |
Chief Tech/Sci/R&D Officer | 50 | 02-27 | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 31/12/13 |
Avery Catlin
BRD | Director/Board Member | 75 | 31/07/14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 30/06/13 |
John Jenkins
BRD | Director/Board Member | 66 | 04/06/18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 07/04/19 |
Yong Ben
BRD | Director/Board Member | 50 | 28/02/23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 05/03/20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 19/09/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,686,693 | 10,434,476 ( 97.64 %) | 0 | 97.64 % |
Company contact information
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+611.75% | 452M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CRBP Stock
- Company Corbus Pharmaceuticals Holdings, Inc.